Refractory Sweet Syndrome Treated with Anakinra

Sweet syndrome, otherwise known as acute febrile neutrophilic dermatosis, is an uncommon disorder characterized by the abrupt onset of painful cutaneous lesions, often with fever and leukocytosis, in patients with underlying infection, malignancy, pregnancy, or drug exposure. We present a case of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Shahid, Zainab, Kalayanamitra, Ricci, Patel, Ravi, Groff, Andrew, Jain, Rohit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2019
Materias:
Dermatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6592472/
https://www.ncbi.nlm.nih.gov/pubmed/31263644
http://dx.doi.org/10.7759/cureus.4536
_version_ 1783429889064435712
author Shahid, Zainab
Kalayanamitra, Ricci
Patel, Ravi
Groff, Andrew
Jain, Rohit
author_facet Shahid, Zainab
Kalayanamitra, Ricci
Patel, Ravi
Groff, Andrew
Jain, Rohit
author_sort Shahid, Zainab
collection PubMed
description Sweet syndrome, otherwise known as acute febrile neutrophilic dermatosis, is an uncommon disorder characterized by the abrupt onset of painful cutaneous lesions, often with fever and leukocytosis, in patients with underlying infection, malignancy, pregnancy, or drug exposure. We present a case of a young female with long-standing Sweet syndrome refractory to standard treatments and several immunomodulators whose symptoms were ultimately controlled with anakinra.
format Online
Article
Text
id pubmed-6592472
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-65924722019-07-01 Refractory Sweet Syndrome Treated with Anakinra Shahid, Zainab Kalayanamitra, Ricci Patel, Ravi Groff, Andrew Jain, Rohit Cureus Dermatology Sweet syndrome, otherwise known as acute febrile neutrophilic dermatosis, is an uncommon disorder characterized by the abrupt onset of painful cutaneous lesions, often with fever and leukocytosis, in patients with underlying infection, malignancy, pregnancy, or drug exposure. We present a case of a young female with long-standing Sweet syndrome refractory to standard treatments and several immunomodulators whose symptoms were ultimately controlled with anakinra. Cureus 2019-04-24 /pmc/articles/PMC6592472/ /pubmed/31263644 http://dx.doi.org/10.7759/cureus.4536 Text en Copyright © 2019, Shahid et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Dermatology
Shahid, Zainab
Kalayanamitra, Ricci
Patel, Ravi
Groff, Andrew
Jain, Rohit
Refractory Sweet Syndrome Treated with Anakinra
title Refractory Sweet Syndrome Treated with Anakinra
title_full Refractory Sweet Syndrome Treated with Anakinra
title_fullStr Refractory Sweet Syndrome Treated with Anakinra
title_full_unstemmed Refractory Sweet Syndrome Treated with Anakinra
title_short Refractory Sweet Syndrome Treated with Anakinra
title_sort refractory sweet syndrome treated with anakinra
topic Dermatology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6592472/
https://www.ncbi.nlm.nih.gov/pubmed/31263644
http://dx.doi.org/10.7759/cureus.4536
work_keys_str_mv AT shahidzainab refractorysweetsyndrometreatedwithanakinra
AT kalayanamitraricci refractorysweetsyndrometreatedwithanakinra
AT patelravi refractorysweetsyndrometreatedwithanakinra
AT groffandrew refractorysweetsyndrometreatedwithanakinra
AT jainrohit refractorysweetsyndrometreatedwithanakinra

Ejemplares similares